1-1 of 1
J. Lundin
Close
Sort by
Journal Articles

Virus Reactivation Profile as Assessed by PCR and Serology Pattern Following First-Line Alemtuzumab (Anti-CD52 Monoclonal Antibody, Campath®) Therapy in Patients with B-CLL.

C. Karlsson, H. Dahl, A. Linde, J. Lundin, M. Björkholm, H. Mellstedt, A. Osterborg
Journal: Blood
Blood (2004) 104 (11): 968.
https://doi.org/10.1182/blood.V104.11.968.968
Published: 2004